Every 8-K that Quantum X Labs Inc. (QXL) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow QXL and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full QXL filings page.
Quantum X Labs Inc. (QXL) reported that on September 15, 2026 it appointed Yossi Cohen, former Director of the Mossad and former National Security Advisor of Israel, as President of its Scientific Advisory Board.
Cohen will work with existing board members to guide Quantum X Labs’ strategy in quantum computing, quantum error correction, quantum cybersecurity, quantum sensing, GPS-denied navigation and precision timing, with a focus on defense, aerospace, homeland security and critical infrastructure applications. The company highlights that Cohen’s current role as a strategic advisor to SoftBank and his 38-year national security career are expected to support its efforts to commercialize quantum technologies and develop international and government-focused partnerships.
Quantum X Labs Inc. filed a report describing the launch of its new 50+ physical qubit neutral-atom quantum computing platform that uses proprietary atom cooling and dynamically reconfigurable optical tweezer arrays. This architecture is designed to support rapid, high-fidelity qubit loading, extended coherence times, and high-performance Rydberg-mediated two-qubit gates.
The company states that its qubit strategy aims to reach thousands of qubits by the end of H1 2027. This roadmap relies on integrating a pending patented deep transformer decoder (US12294387B2), an AI-based error correction system coupled to the neutral-atom control stack to enable low-latency, syndrome-guided error correction and a pathway toward fault-tolerant logical qubit operations.
According to the disclosure, the platform is intended to strengthen Quantum X Labs’ broader quantum portfolio in computing, software and simulation, and sensing, and is aimed at advanced applications such as aerospace and defense, clinical trials, process optimization, nuclear energy, pharmaceuticals, and quantum cybersecurity.
Quantum X Labs Inc. appointed Yakov Baranes as co-Chief Executive Officer, effective May 18, 2026, alongside existing CEO Amihay Hadad, who will continue in a co-CEO structure. Baranes has 11 years of strategy experience across industries and government entities and has led Quantum X Labs Ltd., the company’s Israeli quantum-focused subsidiary, since March 2025.
Under a new agreement effective June 1, 2026, Baranes will receive a base salary of NIS 36,000 + VAT per month as co-CEO, plus NIS 24,000 + VAT per month for services to Quantum Israel, with eligibility for board-determined bonuses. The agreement is open-ended with a 60-day termination notice by either party, and immediate termination for cause is permitted.
In the March 2026 acquisition of Quantum Israel, Baranes, who previously held 32,647 shares (approximately 5.54%) of Quantum Israel, received 103,373 shares of common stock and pre-funded warrants to purchase 246,387 shares of Quantum X Labs common stock and may receive up to an additional 703,710 shares or pre-funded warrants upon achieving specified milestones.
Quantum X Labs Inc. is providing audited 2025 financials and pro forma data for its March 4, 2026 acquisition of Quantum X Labs Ltd. in Israel. The acquired business generated no revenue in 2025, recorded a $325 thousand net loss and faces a going concern uncertainty due to ongoing losses and financing needs. Pro forma 2025 results combine $1.57 million of revenue with a $21.14 million net loss. The acquisition reflects a total purchase cost of $15.89 million, including a $10.67 million share and warrant consideration and a $5.22 million earn-out, creating $20.72 million of goodwill and $3.65 million of intangible assets on the combined balance sheet.